ArticleMedical hypothesis, discovery & innovation ophthalmology journal2026
Association of tobacco smoke exposure with dry-eye symptoms and ocular surface signs.
Article in Medical hypothesis, discovery & innovation ophthalmology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dry eye disease is a multifactorial ocular-surface disorder. Tobacco smoke exposure has been associated with ocular discomfort and altered tear-film measures, although findings remain inconsistent. This study compared dry-eye symptoms and ocular-surface signs between tobacco smoke-exposed and non-exposed participants. Methods: This cross-sectional reanalysis used a retrospective, de-identified dataset collected in Gaza in 2023. The sample comprised 81 participants: 40 tobacco smoke-exposed and 41 non-exposed controls. Exposure was defined by a pooled self-reported binary item encompassing cigarette smoking, shisha use, passive smoke exposure, or combinations thereof. Arab Ocular Surface Disease Index (Arab-OSDI) score was the primary outcome; tear break-up time (TBUT), Schirmer I test with topical anesthesia (STT), and corneal fluorescein staining (CFS) were secondary outcomes. All 81 records were analyzed with adjustment for sex and age category. Arab-OSDI, TBUT, and STT used ordinary least-squares regression with HC3 heteroscedasticity-consistent standard errors (SEs); CFS used proportional-odds ordinal logistic regression with HC3 covariance. Sensitivity analyses included median quantile regression for Arab-OSDI, log-transformed TBUT regression, and age-category frequency matching. Results: Baseline age and sex distributions did not differ significantly between groups ( Conclusions: Tobacco smoke exposure was associated with greater dry-eye symptom burden. No statistically significant associations were identified for TBUT, STT, or CFS. Arab-OSDI sensitivity estimates were similar in magnitude and direction, although the median-regression result was not statistically significant. Because exposure pooled cigarette smoking, shisha use, and passive smoke exposure, the findings cannot be interpreted as the isolated effect of active cigarette smoking. Future studies should distinguish these exposure modalities and quantify exposure intensity and duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.